The biology of glucagon and the consequences of hyperglucagonemia
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2016/11/01
-
Journal
-
Indian UGC (journal)
-
Refrences93
-
Citations77
-
Nicolai J Wewer Albrechtsen Department of Biomedical Sciences, Faculty of Health & Medical Sciences, University of Copenhagen, DenmarkNovo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health & Medical Sciences, University of Copenhagen, Denmark
-
Rune E Kuhre Department of Biomedical Sciences, Faculty of Health & Medical Sciences, University of Copenhagen, DenmarkNovo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health & Medical Sciences, University of Copenhagen, Denmark
-
Jens Pedersen Department of Biomedical Sciences, Faculty of Health & Medical Sciences, University of Copenhagen, DenmarkNovo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health & Medical Sciences, University of Copenhagen, Denmark
-
Filip K Knop Department of Biomedical Sciences, Faculty of Health & Medical Sciences, University of Copenhagen, DenmarkNovo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health & Medical Sciences, University of Copenhagen, DenmarkCenter for Diabetes Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark
-
Jens J Holst Department of Biomedical Sciences, Faculty of Health & Medical Sciences, University of Copenhagen, DenmarkNovo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health & Medical Sciences, University of Copenhagen, Denmark
Abstract
Cite
Wewer Albrechtsen, Nicolai J, et al. “The Biology of Glucagon and the Consequences of Hyperglucagonemia”. Biomarkers in Medicine, vol. 10, no. 11, 2016, pp. 1141-5, https://doi.org/10.2217/bmm-2016-0090.
Wewer Albrechtsen, N. J., Kuhre, R. E., Pedersen, J., Knop, F. K., & Holst, J. J. (2016). The biology of glucagon and the consequences of hyperglucagonemia. Biomarkers in Medicine, 10(11), 1141-1151. https://doi.org/10.2217/bmm-2016-0090
Wewer Albrechtsen, Nicolai J, Rune E Kuhre, Jens Pedersen, Filip K Knop, and Jens J Holst. “The Biology of Glucagon and the Consequences of Hyperglucagonemia”. Biomarkers in Medicine 10, no. 11 (2016): 1141-51. https://doi.org/10.2217/bmm-2016-0090.
Wewer Albrechtsen NJ, Kuhre RE, Pedersen J, Knop FK, Holst JJ. The biology of glucagon and the consequences of hyperglucagonemia. Biomarkers in Medicine. 2016;10(11):1141-5.
Journal Categories
Medicine
Medicine (General)
Science
Biology (General)
Genetics
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
Do glucagonomas always produce glucagon? | Bosnian Journal of Basic Medical Sciences |
| 5 | 2016 |
| 10.1016/S0021-9258(18)85474-6 | Journal of Biological Chemistry |
| 1923 | |
| 10.1016/S0021-9258(18)85474-6 | 2014 | |||
| 10.1016/S0021-9258(18)85474-6 | 2011 | |||
| 10.1016/S0021-9258(18)85474-6 | 2008 |
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
A genetic mouse model of lean-NAFLD unveils sexual dimorphism in the liver-heart axis | Communications Biology |
| 2024 | |
| An orally available compound suppresses glucagon hypersecretion and normalizes hyperglycemia in type 1 diabetes | JCI Insight |
| 2024 | |
| Lowest Glucagon/Highest C-Peptide in Oral Glucose Tolerance Test: Clinical Utility in Monitoring Glucose Control in Type 2 Diabetes Mellitus | Diabetes, Metabolic Syndrome and Obesity |
| 2024 | |
| 100 years of glucagon and 100 more | Diabetologia |
| 16 | 2023 |
| Sarcopenia in the Cirrhotic Patient: Current Knowledge and Future Directions | Journal of Clinical and Experimental Hepatology |
| 6 | 2023 |
Citations Analysis
The category
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the endocrine glands. Clinical endocrinology 41
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Pathophysiology of Non Alcoholic Fatty Liver Disease and was published in 2016. The most recent citation comes from a 2024 study titled Lowest Glucagon/Highest C-Peptide in Oral Glucose Tolerance Test: Clinical Utility in Monitoring Glucose Control in Type 2 Diabetes Mellitus. This article reached its peak citation in 2022, with 18 citations. It has been cited in 53 different journals, 35% of which are open access. Among related journals, the Diabetes cited this research the most, with 5 citations. The chart below illustrates the annual citation trends for this article.